Nesta página
BCYC Bicycle Therapeutics plc - American Depositary Shares
NASDAQ · Biotechnology · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Jul 30, 2026
$3,38
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$3,33mínima 52 sem
$9,16máxima 52 sem
Capitalização de Mercado (MRQ)
$236M
P/E (TTM)
-1.2
EPS (TTM)
$-2.73
Receita (TTM)
$61M
seus distintivos
Intervalo 52 Semanas
$3–$9
Classificação do Analista
BUY
Preço-Alvo
$10
P/E
-1.2
ROE
-32.3%
Margem de Lucro Líquido
-311.1%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
BCYC Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$3.38
Capitalização de Mercado (MRQ)
$236M
P/E (TTM)
-1.2
EPS (TTM)
$-2.73
Receita (TTM)
$61M
ROE (TTM)
-32.3%
Intervalo 52 Semanas
$3–$9
BCYC Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Sobre Bicycle Therapeutics plc - American Depositary Shares Visão geral da empresa da Wikipedia
setorHealthcare
indústriaBiotechnology
funcionários288
paísGB
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$73M2017-12-31 → 2025-12-31
EPS$-3.162019-12-31 → 2025-12-31
Fluxo de caixa livre$-252M2019-12-31 → 2025-12-31
Margem líquida-311.1%2019-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | BCYC | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | -1.2média 5A ≈-8.2 | ≈-8.2 | · | · | |
| P/S (TTM) | 3.9média 5A ≈55.5 | ≈55.5 | · | · | |
| P/B (MRQ) | 0.5média 5A ≈2.5 | ≈2.5 | · | · | |
| Preço / FCF (TTM) | -1.1média 5A ≈-27.1 | ≈-27.1 | · | · | |
| Preço / Fluxo de Caixa (TTM) | -1.1média 5A ≈-30.5 | ≈-30.5 | · | · | |
| Price / Tangible Book (Preço / Valor Patrimonial Tangível) | 0.4média 5A ≈2.5 | ≈2.5 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | BCYC | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | -343.6%média 5A ≈-601.4% | ≈-601.4% | · | · | |
| Margem EBITDA (TTM) | -335.0%média 5A ≈-583.2% | ≈-583.2% | · | · | |
| Margem de Impostos Pré-Tributação (TTM) | -308.3%média 5A ≈-566.8% | ≈-566.8% | · | · | |
| Margem de Lucro Líquido (TTM) | -311.1%média 5A ≈-560.2% | ≈-560.2% | · | · | |
| ROA (TTM) | -26.5%média 5A ≈-26.0% | ≈-26.0% | -41.9% | Primeira linha | |
| ROE (TTM) | -32.3%média 5A ≈-33.4% | ≈-33.4% | -109.6% | Primeira linha | |
| ROIC | -40.5%média 5A ≈-33.8% | ≈-33.8% | -96.7% | Primeira linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | BCYC | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 12.1média 5A ≈10.7 | ≈10.7 | 4.9 | Liquidez forte | |
| Quick Ratio (Índice de Liquidez Seca) | 11.0média 5A ≈10.0 | ≈10.0 | 3.1 | Liquidez forte |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | BCYC | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 105.8%média 5A ≈51.9% | ≈51.9% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 71.2%média 5A ≈51.0% | ≈51.0% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 47.5% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | BCYC | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.1média 5A ≈0.1 | ≈0.1 | · | · | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$252.0K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
2.7%
Próximo relatório
Out 28, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 6, 2026 | $-0.72 | $-0.59 | -22.6% |
| 31 de Março de 2026 | $-0.87 | $-0.63 | -37.4% | |
| 31 de Dezembro de 2025 | $-0.29 | $-0.96 | 69.7% | |
| 30 de Setembro de 2025 | $-0.85 | $-1.10 | 22.7% | |
| 30 de Junho de 2025 | $-1.14 | $-0.97 | -17.5% | |
| 31 de Março de 2025 | $-0.88 | $-0.86 | -2.4% | |
| 31 de Dezembro de 2024 | $-0.82 | $-0.88 | 6.4% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73M | $35M | $27M | $14M | $12M | $10M | $14M | $7M | |
| R&D Expense | $240M | $173M | $156M | $82M | $45M | $33M | $26M | $21M | |
| SG&A Expense | $79M | $72M | $60M | $50M | $32M | $29M | $15M | $8M | |
| Operating Expenses | $320M | $245M | $217M | $131M | $77M | $62M | $40M | $29M | |
| Operating Income | $-247M | $-210M | $-190M | $-117M | $-66M | $-52M | $-26M | $-22M | |
| Interest Expense | · | · | $3M | $3M | $3M | $457.0K | · | · | |
| Other Non-op | $28M | $36M | $11M | $2M | $-3M | $226.0K | $-5M | $-665.0K | |
| Pretax Income | $-219M | $-174M | $-179M | $-114M | $-68M | $-52M | $-31M | $-22M | |
| Income Tax | $152.0K | $-5M | $1M | $-2M | $-2M | $-724.0K | $-254.0K | $-396.0K | |
| Net Income | $-219M | $-169M | $-181M | $-113M | $-67M | $-51M | $-31M | $-22M | |
| EPS (Basic) | $-3.16 | $-2.90 | $-5.08 | $-3.80 | $-2.67 | $-2.66 | $-2.77 | · | |
| EPS (Diluted) | $-3.16 | $-2.90 | $-5.08 | $-3.80 | $-2.67 | $-2.66 | $-2.77 | · | |
| Shares (Basic) | 69,279,838 | 58,207,593 | 35,592,362 | 29,660,659 | 25,061,734 | 19,145,938 | 11,045,370 | · | |
| Shares (Diluted) | 69,279,838 | 58,207,593 | 35,592,362 | 29,660,659 | 25,061,734 | 19,145,938 | 11,045,370 | · | |
| EBITDA | $-241M | $-203M | $-183M | $-113M | $-64M | $-51M | $-25M | · |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $628M | $880M | $526M | $339M | $439M | $136M | $0 | $0 | |
| Receivables | $0 | $0 | $0 | $2M | $1M | $5M | $201.0K | $5M | |
| Prepaid Expense | $19M | $13M | $11M | $9M | $8M | $5M | $5M | $2M | |
| Current Assets | $683M | $929M | $562M | $369M | $459M | $156M | $104M | $77M | |
| PP&E (Net) | $6M | $10M | $15M | $19M | $3M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $28M | $27M | $8M | $6M | $5M | $4M | |
| Accum. Depreciation | · | · | $13M | $8M | $5M | $4M | $3M | $2M | |
| Other Non-current Assets | $13M | $11M | $6M | $8M | $3M | $2M | $2M | $3M | |
| Total Assets | $718M | $957M | $595M | $411M | $480M | $161M | $110M | $82M | |
| Accounts Payable | $10M | $16M | $13M | $6M | $3M | $1M | $2M | $2M | |
| Accrued Liabilities | $44M | $41M | $32M | $26M | $14M | $12M | $6M | $7M | |
| Current Liabilities | $57M | $67M | $70M | $53M | $36M | $23M | $9M | $9M | |
| Capital Leases | $14M | $4M | $9M | $11M | $12M | $426.0K | $1M | · | |
| Other Non-current Liabilities | $1M | $1M | $5M | $4M | $3M | $3M | $2M | $897.0K | |
| Total Liabilities | $108M | $164M | $224M | $140M | $134M | $66M | $17M | $29M | |
| Long-term Debt | · | · | $31M | $30M | $30M | $15M | · | · | |
| Total Debt | · | · | $31M | $30M | $30M | $15M | · | · | |
| Common Stock | $894.0K | $890.0K | $550.0K | $387.0K | $384.0K | $266.0K | $227.0K | $10.0K | |
| Paid-in Capital | $1.51B | $1.47B | $883M | $601M | $568M | $250M | $195M | $2M | |
| Retained Earnings | $-900M | $-681M | $-512M | $-331M | $-218M | $-152M | $-101M | $-70M | |
| AOCI | $-4M | $119.0K | $-1M | $387.0K | $-3M | $-3M | $-2M | $-2M | |
| Stockholders' Equity | $610M | $793M | $371M | $271M | $346M | $95M | $93M | $-70M | |
| Liabilities + Equity | $718M | $957M | $595M | $411M | $480M | $161M | $110M | $82M | |
| Shares Outstanding | 69,367,896 | 69,061,418 | 42,431,766 | 29,873,893 | 29,579,364 | 21,094,557 | 17,993,701 | 814,728 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $7M | $7M | $4M | $1M | $1M | $960.0K | $712.0K | |
| Stock-based Comp | $39M | $38M | $32M | $27M | $12M | $7M | $3M | $1M | |
| Deferred Tax | $-850.0K | $-5M | $3M | $-5M | $-2M | $-673.0K | $-364.0K | $-378.0K | |
| Restructuring | · | $2M | · | · | · | · | · | · | |
| Other Non-cash | $-76M | $-36M | $78M | $1M | $40M | $26M | $-2M | · | |
| Operating Cash Flow | $-250M | $-165M | $-61M | $-86M | $-15M | $-18M | $-29M | $-26M | |
| CapEx | $2M | $1M | $3M | $19M | $2M | $1M | $2M | $1M | |
| Investing Cash Flow | $-2M | $-1M | $-3M | $-19M | $-2M | $-1M | $-2M | $-1M | |
| Net Debt Issued | · | $-32M | · | · | · | · | · | · | |
| Stock Issued | · | $544M | $249M | $6M | $291M | $48M | · | · | |
| Net Stock Activity | · | $544M | $249M | $6M | $8M | · | · | · | |
| Financing Cash Flow | $-131.0K | $520M | $250M | $7M | $321M | $63M | $58M | $25M | |
| Net Change in Cash | $-251M | $353M | $188M | $-100M | $303M | $44M | $29M | $-4M | |
| Taxes Paid | $-717.0K | $792.0K | $562.0K | $2M | $73.0K | $124.0K | $117.0K | $73.0K | |
| Free Cash Flow | $-252M | $-166M | $-64M | $-105M | $-17M | $-19M | $-30M | · | |
| Levered FCF | · | · | $-67M | $-108M | $-20M | $-19M | · | · |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -340.4% | -595.0% | -704.1% | -806.6% | -561.0% | -500.1% | -190.6% | · | |
| Net Margin | -301.7% | -479.2% | -669.7% | -779.4% | -571.2% | -490.9% | -221.8% | · | |
| Pretax Margin | -301.4% | -492.7% | -664.3% | -789.9% | -585.5% | -497.9% | -223.6% | · | |
| EBITDA Margin | -331.5% | -574.6% | -679.9% | -781.1% | -548.9% | -487.8% | -183.6% | · | |
| ROA | -26.2% | -21.8% | -35.9% | -25.3% | -20.8% | -37.6% | -31.9% | · | |
| ROE | -34.2% | -20.8% | -45.9% | -40.2% | -25.8% | -49.8% | -32.5% | · | |
| ROIC | -40.5% | -25.7% | -47.7% | -38.2% | -17.0% | -46.6% | -28.0% | · |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.0 | 13.8 | 8.1 | 6.9 | 12.7 | 6.7 | 11.8 | · | |
| Quick Ratio | 11.0 | 13.1 | 7.6 | 6.4 | 12.1 | 0.2 | 0.0 | · | |
| Debt / Equity | · | · | 0.1 | 0.1 | 0.1 | 0.2 | · | · | |
| LT Debt / Equity | · | · | 0.1 | 0.1 | 0.1 | 0.2 | · | · | |
| Interest Coverage | · | · | -58.2 | -34.9 | -22.0 | -113.7 | · | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | · | 26.4 | 9.5 | 3.6 | 3.7 | 5.3 | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.79 | $11.48 | $8.74 | $9.06 | $11.71 | $4.53 | $5.18 | · | |
| Revenue / Share | $1.05 | $0.61 | $0.76 | $0.49 | $0.47 | · | · | · | |
| Cash Flow / Share | $-3.60 | $-2.83 | $-1.70 | $-2.90 | $-0.59 | · | · | · | |
| Cash / Share | $9.05 | $12.74 | $12.41 | $11.35 | $14.83 | $0.00 | $0.00 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | |
| EPS (TTM) | $-3.16 | $-2.90 | $-5.08 | $-3.80 | $-2.67 | $-2.66 | $-2.77 | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 105.8% | 30.8% | 86.5% | 23.6% | 12.6% | · | · | · | |
| Revenue CAGR 3Y | 71.2% | 44.5% | 37.4% | · | · | · | · | · | |
| Revenue CAGR 5Y | 47.5% | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $73M | $35M | $27M | $14M | $12M | $10M | $14M | · | |
| Net Income TTM | $-219M | $-169M | $-181M | $-113M | $-67M | $-51M | $-31M | · | |
| Market Cap | $491M | $967M | $767M | $884M | $1.80B | $379M | $170M | · | |
| Enterprise Value | · | · | $271M | $575M | $1.39B | $393M | · | · | |
| P/E | -2.2 | -4.8 | -3.6 | -7.8 | -22.8 | -6.7 | -3.4 | · | |
| P/S | 6.8 | 27.4 | 28.4 | 61.1 | 153.9 | 36.4 | 12.3 | · | |
| P/B | 0.8 | 1.2 | 2.1 | 3.3 | 5.2 | 4.0 | 1.8 | · | |
| P / Tangible Book | 0.8 | 1.2 | 2.1 | 3.3 | 5.2 | 4.0 | · | · | |
| P / Cash Flow | -2.0 | -5.9 | -12.7 | -10.3 | -121.7 | -21.3 | -5.9 | · | |
| P / FCF | -1.9 | -5.8 | -12.1 | -8.4 | -107.0 | -19.9 | -5.6 | · | |
| EV / EBITDA | · | · | -1.5 | -5.1 | -21.7 | -7.8 | · | · | |
| EV / FCF | · | · | -4.3 | -5.5 | -82.7 | -20.7 | · | · | |
| EV / Revenue | · | · | 10.1 | 39.8 | 119.0 | 37.8 | · | · | |
| Earnings Yield | -44.6% | -20.7% | -28.1% | -12.8% | -4.4% | -14.8% | -29.4% | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $629.0K | $887.0K | $48M | $12M | $3M | $10M | $4M | $3M | $9M | $20M | $5M | $5M | $11M | $5M | $3M | $3M | |
| R&D Expense | $41M | $49M | $52M | $58M | $71M | $59M | $50M | $48M | $40M | $35M | $45M | $40M | $40M | $32M | $25M | $23M | |
| SG&A Expense | $14M | $17M | $21M | $19M | $18M | $21M | $22M | $18M | $16M | $16M | $15M | $16M | $15M | $14M | $11M | $10M | |
| Operating Expenses | $55M | $66M | $73M | $77M | $90M | $80M | $71M | $67M | $56M | $51M | $60M | $56M | $55M | $47M | $35M | $33M | |
| Operating Income | $-55M | $-65M | $-25M | $-66M | $-87M | $-70M | $-68M | $-64M | $-47M | $-32M | $-54M | $-51M | $-43M | $-42M | $-32M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $821.0K | · | $814.0K | $821.0K | $808.0K | · | $817.0K | |
| Other Non-op | $4M | $5M | $6M | $7M | $7M | $8M | $15M | $10M | $7M | $5M | $5M | $3M | $-9.0K | $2M | $2M | $1M | |
| Pretax Income | $-50M | $-61M | $-19M | $-59M | $-79M | $-62M | $-53M | $-54M | $-40M | $-27M | $-49M | $-48M | $-43M | $-40M | $-30M | $-29M | |
| Income Tax | $90.0K | $172.0K | $1M | $205.0K | $-231.0K | $-1M | $-1M | $-3M | $115.0K | $-350.0K | $320.0K | $2M | $-517.0K | $-618.0K | $-420.0K | $-238.0K | |
| Net Income | $-50M | $-61M | $-20M | $-59M | $-79M | $-61M | $-52M | $-51M | $-40M | $-27M | $-49M | $-50M | $-43M | $-39M | $-30M | $-28M | |
| EPS (Basic) | $-0.72 | $-0.87 | $-0.29 | $-0.85 | $-1.14 | $-0.88 | $-0.77 | $-0.74 | $-0.77 | $-0.62 | $-1.11 | $-1.26 | $-1.41 | $-1.30 | $-1.01 | $-0.96 | |
| EPS (Diluted) | $-0.72 | $-0.87 | $-0.29 | $-0.85 | $-1.14 | $-0.88 | $-0.77 | $-0.74 | $-0.77 | $-0.62 | $-1.11 | $-1.26 | $-1.41 | $-1.30 | $-1.01 | $-0.96 | |
| Shares (Basic) | 69,804,828 | 69,683,471 | · | 69,303,746 | 69,252,009 | 69,196,945 | · | 68,988,858 | 51,992,034 | 42,560,091 | · | 39,576,467 | 30,191,693 | 30,001,725 | · | 29,676,021 | |
| Shares (Diluted) | 69,804,828 | 69,683,471 | · | 69,303,746 | 69,252,009 | 69,196,945 | · | 68,988,858 | 51,992,034 | 42,560,091 | · | 39,576,467 | 30,191,693 | 30,001,725 | · | 29,676,021 | |
| EBITDA | $-55M | $-64M | · | $-66M | $-87M | $-69M | · | $-64M | $-47M | $-30M | · | $-51M | $-43M | $-40M | · | $-30M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $510M | $559M | $628M | $648M | $721M | $793M | $880M | $891M | $961M | $457M | $526M | $572M | $340M | $294M | $339M | $361M | |
| Receivables | · | · | $0 | · | · | $136.0K | $0 | · | $233.0K | · | · | $0 | $45M | $50M | · | $0 | |
| Prepaid Expense | $18M | $19M | $19M | $23M | $22M | $17M | $13M | $17M | $20M | $20M | · | $14M | $10M | $11M | · | $8M | |
| Current Assets | $575M | $619M | $683M | $739M | $804M | $856M | $929M | $966M | $1.03B | $516M | · | $603M | $408M | $381M | · | $381M | |
| PP&E (Net) | $5M | $6M | $6M | $7M | $8M | $9M | $10M | $12M | $12M | $13M | · | $16M | $18M | $18M | · | $16M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | $28M | $28M | · | $27M | $28M | $27M | · | $22M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | $17M | $15M | · | $11M | $10M | $9M | · | $6M | |
| Other Non-current Assets | $13M | $13M | $13M | $14M | $14M | $12M | $11M | $10M | $7M | $6M | · | $5M | $12M | $11M | · | $6M | |
| Total Assets | $607M | $652M | $718M | $764M | $832M | $884M | $957M | $997M | $1.06B | $547M | · | $639M | $454M | $429M | · | $417M | |
| Accounts Payable | $6M | $6M | $10M | $13M | $18M | $11M | $16M | $6M | $7M | $7M | · | $8M | $5M | $3M | · | $7M | |
| Accrued Liabilities | $39M | $40M | $44M | $44M | $45M | $34M | $41M | $39M | $28M | $26M | · | $34M | $37M | $25M | · | $18M | |
| Current Liabilities | $48M | $49M | $57M | $69M | $77M | $58M | $67M | $56M | $70M | $50M | · | $70M | $72M | $53M | · | $42M | |
| Capital Leases | $14M | $14M | $14M | $981.0K | $2M | $3M | $4M | $6M | $7M | $8M | · | $10M | $12M | $14M | · | $11M | |
| Other Non-current Liabilities | $931.0K | $973.0K | $1M | $1M | $1M | $1M | $1M | $6M | $5M | $5M | · | $4M | $4M | $4M | · | $3M | |
| Total Liabilities | $96M | $98M | $108M | $145M | $163M | $144M | $164M | $166M | $184M | $191M | · | $223M | $234M | $186M | · | $128M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $31M | $31M | · | $31M | $31M | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | $31M | $31M | · | $31M | $31M | $30M | · | $30M | |
| Common Stock | $900.0K | $899.0K | $894.0K | $894.0K | $893.0K | $892.0K | $890.0K | $890.0K | $889.0K | $553.0K | · | $550.0K | $396.0K | $389.0K | · | $385.0K | |
| Paid-in Capital | $1.53B | $1.52B | $1.51B | $1.50B | $1.49B | $1.48B | $1.47B | $1.46B | $1.45B | $895M | · | $875M | $633M | $613M | · | $590M | |
| Retained Earnings | $-1.01B | $-961M | $-900M | $-880M | $-820M | $-742M | $-681M | $-629M | $-578M | $-538M | · | $-463M | $-413M | $-370M | · | $-301M | |
| AOCI | $-5M | $-5M | $-4M | $-3M | $-3M | $-1M | $119.0K | $-3M | $-1M | $-778.0K | · | $3M | $-877.0K | $71.0K | · | $528.0K | |
| Stockholders' Equity | $510M | $554M | $610M | $618M | $669M | $740M | $793M | $831M | $874M | $356M | $371M | $416M | $220M | $243M | $271M | $289M | |
| Liabilities + Equity | $607M | $652M | $718M | $764M | $832M | $884M | $957M | $997M | $1.06B | $547M | · | $639M | $454M | $429M | · | $417M | |
| Shares Outstanding | 69,814,145 | 69,707,026 | 69,367,896 | 69,306,511 | 69,253,944 | 69,202,355 | 69,061,418 | 69,015,971 | 68,941,242 | 42,632,597 | 42,431,766 | 42,384,799 | 30,585,940 | 30,031,758 | 29,873,893 | 29,678,431 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Stock-based Comp | $6M | $7M | $12M | $9M | $9M | $10M | $10M | $9M | $9M | $9M | $8M | $7M | $8M | $9M | $6M | $5M | |
| Deferred Tax | $326.0K | $-241.0K | $843.0K | $-46.0K | $-331.0K | $-1M | $-1M | $-3M | $-110.0K | $-767.0K | $-282.0K | $7M | $-2M | $-2M | $-2M | $-1M | |
| Restructuring | · | · | · | · | · | · | · | $2M | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-13M | · | · | · | $-36M | · | · | · | $-54M | · | · | · | $-16M | · | · | |
| Operating Cash Flow | $-50M | $-66M | $-19M | $-71M | $-73M | $-86M | $-9M | $-40M | $-45M | $-71M | $-47M | $-1M | $34M | $-46M | $-30M | $-6M | |
| CapEx | $265.0K | $713.0K | $574.0K | $674.0K | $498.0K | $604.0K | $368.0K | $435.0K | $420.0K | $12.0K | $51.0K | $502.0K | $277.0K | $2M | $1M | $3M | |
| Investing Cash Flow | $-265.0K | $-713.0K | $-574.0K | $-674.0K | $-498.0K | $-604.0K | $-368.0K | $-435.0K | $-420.0K | $-12.0K | $-51.0K | $-502.0K | $-277.0K | $-2M | $-1M | $-3M | |
| Stock Issued | · | · | · | · | · | · | $0 | $-979.0K | · | · | $10.0K | $234M | $12M | $3M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | · | · | |
| Financing Cash Flow | $-50.0K | $-54.0K | $-15.0K | $-30.0K | $-45.0K | $-41.0K | $203.0K | $-32M | $550M | $2M | $386.0K | $235M | $12M | $3M | $6M | $159.0K | |
| Net Change in Cash | $-50M | $-69M | $-20M | $-73M | $-72M | $-87M | $-11M | $-71M | $504M | $-69M | $-46M | $232M | $47M | $-45M | $-22M | $-11M | |
| Taxes Paid | · | · | $171.0K | $233.0K | · | · | $0 | $0 | · | · | $-102.0K | $0 | · | · | $1M | $454.0K | |
| Free Cash Flow | · | $-67M | · | · | · | $-87M | · | · | · | $-71M | · | · | · | $-49M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-72M | · | · | · | $-49M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8673.9% | -7382.4% | · | -558.6% | -2965.8% | -703.7% | · | -2385.9% | -498.3% | -162.4% | · | · | · | -853.8% | · | -978.9% | |
| Net Margin | -8002.1% | -6857.4% | · | -503.7% | -2703.8% | -608.9% | · | -1898.4% | -425.3% | -136.0% | · | · | · | -797.9% | · | -932.5% | |
| Pretax Margin | -7987.8% | -6838.0% | · | -501.9% | -2711.8% | -619.8% | · | -2027.3% | -424.1% | -137.8% | · | · | · | -810.5% | · | -940.3% | |
| EBITDA Margin | -8673.9% | -7255.1% | · | -558.6% | -2965.8% | -687.3% | · | -2385.9% | -498.3% | -153.9% | · | · | · | -822.0% | · | -978.9% | |
| ROA | -7.0% | -7.9% | · | -6.7% | -8.4% | -8.5% | · | -6.2% | -5.3% | -5.4% | · | -9.4% | -9.5% | -8.8% | · | -8.1% | |
| ROE | -8.5% | -9.4% | · | -8.2% | -10.2% | -11.1% | · | -8.2% | -7.3% | -8.9% | · | -14.1% | -16.0% | -13.6% | · | -12.3% | |
| ROIC | -10.7% | -11.8% | · | -10.6% | -12.9% | -9.3% | · | -7.2% | -5.2% | -8.1% | · | -11.9% | -17.0% | -15.0% | · | -9.2% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.1 | 12.7 | · | 10.7 | 10.4 | 14.9 | · | 17.1 | 14.8 | 10.4 | · | 8.6 | 5.7 | 7.2 | · | 9.2 | |
| Quick Ratio | 10.7 | 11.4 | · | 9.4 | 9.3 | 13.8 | · | 15.8 | 13.8 | 9.2 | · | 8.2 | 5.3 | 6.5 | · | 8.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | 0.0 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -38.6 | · | -62.4 | -52.5 | -51.7 | · | -36.4 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | 0.4 | · | · | 0.4 | · | · | · | · | 0.2 | · | 2.1 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.31 | $7.95 | · | $8.92 | $9.66 | $10.70 | · | $12.04 | $12.67 | $8.35 | · | $9.82 | $7.20 | $8.10 | · | $9.75 | |
| Revenue / Share | $0.01 | $0.01 | · | $0.17 | $0.04 | $0.14 | · | $0.04 | $0.18 | $0.46 | · | · | · | $0.16 | · | $0.10 | |
| Cash Flow / Share | · | $-0.95 | · | · | · | $-1.25 | · | · | · | $-1.67 | · | · | · | $-1.55 | · | · | |
| Cash / Share | $7.31 | $8.03 | · | $9.35 | $10.42 | $11.46 | · | $12.91 | $13.94 | $10.72 | · | $13.50 | $11.13 | $9.78 | · | $12.18 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| EPS (TTM) | $-2.73 | $-3.15 | · | $-3.64 | $-3.53 | $-3.16 | · | $-3.24 | $-3.76 | $-4.40 | · | $-4.98 | $-4.68 | $-4.17 | · | $-3.40 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $61M | $63M | · | $28M | $19M | $26M | · | $37M | $40M | $42M | · | $25M | $23M | $15M | · | $15M | |
| Net Income TTM | $-190M | $-219M | · | $-251M | $-242M | $-203M | · | $-166M | $-165M | $-168M | · | $-162M | $-140M | $-124M | · | $-101M | |
| Market Cap | $296M | $323M | · | $536M | $481M | $588M | · | $1.56B | $1.40B | $1.06B | · | $852M | $781M | $639M | · | $690M | |
| Enterprise Value | · | · | · | · | · | · | · | · | $465M | $635M | · | $310M | $471M | $375M | · | $359M | |
| P/E | -1.6 | -1.5 | · | -2.1 | -2.0 | -2.7 | · | -7.0 | -5.4 | -5.7 | · | -4.0 | -5.5 | -5.1 | · | -6.8 | |
| P/S | 4.8 | 5.1 | · | 18.9 | 25.0 | 22.8 | · | 42.3 | 35.3 | 25.5 | · | 34.3 | 34.7 | 41.2 | · | 45.9 | |
| P/B | 0.6 | 0.6 | · | 0.9 | 0.7 | 0.8 | · | 1.9 | 1.6 | 3.0 | · | 2.0 | 3.5 | 2.6 | · | 2.4 | |
| P / Tangible Book | 0.6 | 0.6 | · | 0.9 | 0.7 | 0.8 | · | 1.9 | 1.6 | 3.0 | · | 2.0 | 3.5 | 2.6 | · | 2.4 | |
| P / Cash Flow | · | -4.9 | · | · | · | -6.8 | · | · | · | -15.0 | · | · | · | -13.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 11.7 | 15.3 | · | 12.5 | 20.9 | 24.2 | · | 23.9 | |
| Earnings Yield | -64.4% | -67.9% | · | -47.0% | -50.8% | -37.2% | · | -14.3% | -18.6% | -17.7% | · | -24.8% | -18.3% | -19.6% | · | -14.6% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $73M | $35M | $27M | $14M | $12M |
| Margem Operacional % | -340.4% | -595.0% | -704.1% | -806.6% | -561.0% |
| Lucro líquido | $-219M | $-169M | $-181M | $-113M | $-67M |
| EPS Diluído | $-3.16 | $-2.90 | $-5.08 | $-3.80 | $-2.67 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | · | · | 0.1 | 0.1 | 0.1 |
| Índice de liquidez corrente | 12.0 | 13.8 | 8.1 | 6.9 | 12.7 |
| Índice de Liquidez Seca | 11.0 | 13.1 | 7.6 | 6.4 | 12.1 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-252M | $-166M | $-64M | $-105M | $-17M |
Investidores institucionais (13F) 114 declarantes · $150.5M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
114
Valor detido
$150.5M
Novas posições
22
Posições encerradas
12
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 22 (+6 vs trimestre anterior) | 12 (-13 vs trimestre anterior) | 37 (-8 vs trimestre anterior) | 19 (+2 vs trimestre anterior) | -102K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $46.153.914 | 10.885.357 | 30,67% | Ações |
| FCPM III SERVICES B.V. | $14.706.143 | 3.468.430 | 9,77% | Ações |
| ARMISTICE CAPITAL, LLC | $14.407.520 | 3.398.000 | 9,57% | Ações |
| Long Focus Capital Management, LLC | $14.037.313 | 3.310.687 | 9,33% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $6.501.616 | 1.533.400 | 4,32% | Ações |
| GSK plc | $6.485.339 | 1.529.561 | 4,31% | Ações |
| MARSHALL WACE, LLP | $3.383.266 | 797.940 | 2,25% | Ações |
| Qube Research & Technologies Ltd | $3.288.404 | 775.567 | 2,19% | Ações |
| MORGAN STANLEY | $2.829.221 | 667.269 | 1,88% | Ações |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2.555.707 | 615.833 | 1,70% | Ações |
| CITADEL ADVISORS LLC | $2.349.914 | 554.225 | 1,56% | Ações |
| MILLENNIUM MANAGEMENT LLC | $2.348.820 | 553.967 | 1,56% | Ações |
| Peapod Lane Capital LLC | $2.281.027 | 537.978 | 1,52% | Ações |
| DIADEMA PARTNERS LP | $1.961.950 | 462.724 | 1,30% | Ações |
| TWO SIGMA INVESTMENTS, LP | $1.842.606 | 434.577 | 1,22% | Ações |
| JANE STREET GROUP, LLC | $1.662.771 | 392.163 | 1,10% | Ações |
| Aquilo Capital Management, LLC | $1.457.691 | 171.695 | 0,97% | Ações |
| Birchview Capital, LP | $1.329.732 | 313.616 | 0,88% | Ações |
| BlackRock, Inc. | $1.188.837 | 280.386 | 0,79% | Ações |
| MOORE CAPITAL MANAGEMENT, LP | $1.166.000 | 275.000 | 0,77% | Ações |
| Rangeley Capital, LLC | $1.074.840 | 253.500 | 0,71% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.042.616 | 245.900 | 0,69% | Opção de venda |
| TWO SIGMA ADVISERS, LP | $1.034.388 | 146.100 | 0,69% | Ações |
| Palo Alto Investors LP | $856.014 | 201.890 | 0,57% | Ações |
| Sculptor Capital LP | $839.113 | 197.904 | 0,56% | Ações |
| Eversept Partners, LP | $808.632 | 190.715 | 0,54% | Ações |
| PINNACLE ASSOCIATES LTD | $805.558 | 189.990 | 0,54% | Ações |
| Cubist Systematic Strategies, LLC | $800.393 | 103.410 | 0,53% | Ações |
| FLAX POND CAPITAL, LLC | $763.565 | 180.086 | 0,51% | Ações |
| Jump Financial, LLC | $708.504 | 167.100 | 0,47% | Ações |
| Point72 Asset Management, L.P. | $635.729 | 149.936 | 0,42% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $542.139 | 127.863 | 0,36% | Ações |
| GOLDMAN SACHS GROUP INC | $514.231 | 121.281 | 0,34% | Ações |
| Persistent Asset Partners Ltd | $497.157 | 117.254 | 0,33% | Ações |
| XTX Topco Ltd | $465.556 | 109.801 | 0,31% | Ações |
| Quadrature Capital Ltd | $441.350 | 104.092 | 0,29% | Ações |
| TD Asset Management Inc | $390.046 | 91.992 | 0,26% | Ações |
| Virtus Investment Advisers, LLC | $342.545 | 80.789 | 0,23% | Ações |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $339.200 | 80.000 | 0,23% | Ações |
| EntryPoint Capital, LLC | $329.630 | 77.743 | 0,22% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $315.880 | 74.500 | 0,21% | Opção de compra |
| Marquette Asset Management, LLC | $308.901 | 72.854 | 0,21% | Ações |
| DAFNA Capital Management LLC | $273.446 | 64.492 | 0,18% | Ações |
| State of Tennessee, Department of Treasury | $259.289 | 61.153 | 0,17% | Ações |
| CITADEL ADVISORS LLC | $238.288 | 56.200 | 0,16% | Opção de venda |
| SEI INVESTMENTS CO | $223.804 | 52.784 | 0,15% | Ações |
| ALPS ADVISORS INC | $216.757 | 51.122 | 0,14% | Ações |
| Verdad Advisers, LP | $216.664 | 51.100 | 0,14% | Ações |
| ADAR1 Capital Management, LLC | $214.705 | 50.638 | 0,14% | Ações |
| JANE STREET GROUP, LLC | $151.792 | 35.800 | 0,10% | Opção de compra |
Ativistas e proprietários de 5%+ 7 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×3 declarações | 17 de Dezembro de 2024 | · | Declaração inicial | · | SEC |
| GSK plc | 20 de Julho de 2023 | · | Declaração inicial | · | SEC |
| Tybourne Capital Management (HK) Limited, Tybourne Capital Management Limited, Tybourne Kesari Limited, Viswanathan Krishnan, Aquila Investments IV ×4 declarações | 14 de Março de 2022 | · | Declaração inicial | · | SEC |
| GlaxoSmithKline plc ×5 declarações | 16 de Setembro de 2021 | · | Declaração inicial | · | SEC |
| SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P. ×2 declarações | 16 de Agosto de 2021 | · | Declaração inicial | · | SEC |
| Vertex Venture Holdings Ltd., Vertex Global HC Fund I Pte. Ltd., Vertex Venture Management Pte. Ltd. ×2 declarações | 20 de Janeiro de 2021 | · | Declaração inicial | Investimento passivo | SEC |
| Cambridge Innovation Capital (Jersey) Limited | 7 de Junho de 2019 | · | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 32 insiders · 14 diretores · 16 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Kevin Lee | CHIEF EXECUTIVE OFFICER | 6 de Julho de 2026 S | 603.671 | 0 | 8 | $-258.045 |
| Travis Alvin Thompson | Chief Financial Officer | 15 de Julho de 2026 A | 64.441 | 0 | 8 | $-27.253 |
| Alethia Young | Chief Financial Officer | 2 de Janeiro de 2026 A | 87.081 | 0 | 5 | $-54.590 |
| Lee Kalowski | President and CFO | 3 de Abril de 2023 S | 30.309 | 0 | 0 | $0 |
| Jennifer Scott Perry | Chief Operating Officer | 15 de Julho de 2026 A | 91.052 | 0 | 6 | $-13.016 |
| Alistair Milnes | CHIEF OPERATING OFFICER | 2 de Janeiro de 2026 A | 136.717 | 0 | 4 | $-61.986 |
| Michael Charles Ferguson Hannay | CHIEF PROD & SUPPLY CHAIN OFF | 15 de Julho de 2026 A | 94.375 | 0 | 8 | $-56.832 |
| Michael Skynner | CHIEF SCIENTIFIC OFFICER | 15 de Julho de 2026 A | 157.171 | 0 | 8 | $-79.059 |
| Eric Westin | Chief Medical Officer | 25 de Março de 2025 A | · | 0 | 0 | $0 |
| Nigel Crockett | CHIEF BUSINESS OFFICER | 2 de Janeiro de 2025 A | 51.053 | 0 | 0 | $0 |
| Santiago Arroyo | CHIEF DEVELOPMENT OFFICER | 2 de Janeiro de 2025 A | 69.057 | 0 | 0 | $0 |
| Nicholas Keen | CHIEF SCIENTIFIC OFFICER | 3 de Julho de 2024 S | 62.024 | 0 | 0 | $0 |
| Dominic Smethurst | Chief Medical Officer | 3 de Janeiro de 2023 A | 36.699 | 0 | 0 | $0 |
| Peter Brian Leone | Chief Business Officer | 28 de Maio de 2019 A | · | 0 | 0 | $0 |
| Robert Charles Swanton | Conselheiro | 2 de Janeiro de 2026 A | 19.213 | 0 | 1 | $-872 |
| Stephen H. Sands | Conselheiro | 2 de Janeiro de 2026 A | 26.893 | 0 | 0 | $0 |
| Alessandro Riva | Conselheiro | 2 de Janeiro de 2026 A | 19.880 | 0 | 0 | $0 |
| Janice Bourque | Conselheiro | 2 de Janeiro de 2026 A | 32.500 | 0 | 0 | $0 |
| Gregory Paul Winter | Conselheiro | 2 de Janeiro de 2026 A | 196.427 | 0 | 0 | $0 |
| Roger D Dansey | Conselheiro | 2 de Janeiro de 2026 A | 15.532 | 0 | 0 | $0 |
| Jose-Carlos Gutierrez-Ramos | Conselheiro | 2 de Janeiro de 2026 A | 32.500 | 0 | 0 | $0 |
| Herve Hoppenot | Conselheiro | 2 de Janeiro de 2026 A | 15.532 | 0 | 0 | $0 |
| Pierre Legault | Conselheiro | 2 de Janeiro de 2025 A | 46.000 | 0 | 0 | $0 |
| Richard N Kender | Conselheiro | 2 de Janeiro de 2025 A | 23.000 | 0 | 0 | $0 |
| Veronica Gh Jordan | Conselheiro | 2 de Janeiro de 2024 A | 16.750 | 0 | 0 | $0 |
| Kate Bingham | Conselheiro | 14 de Julho de 2021 S | 38.708 | 0 | 0 | $0 |
| Carolyn Ng | Conselheiro | 28 de Maio de 2019 C | 1.427.151 | 0 | 0 | $0 |
| Deborah Harland | Conselheiro | 28 de Maio de 2019 C | 1.915.275 | 0 | 0 | $0 |
| Michael Anstey | Conselheiro | 28 de Maio de 2019 C | 1.751.437 | 0 | 0 | $0 |
| Cambridge Innovation Capital (Jersey) Ltd | Detentor de 10% | 28 de Maio de 2019 C | 1.751.437 | 0 | 0 | $0 |
| Vertex Global Healthcare Fund I Pte Ltd. | Detentor de 10% | 28 de Maio de 2019 C | 1.621.168 | 0 | 0 | $0 |
| GSK plc | · | 15 de Julho de 2020 S | 1.910.531 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 4 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,64% | 76.743 NS | 31 de Julho de 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,45% | 29.023 SH | 2 de Outubro de 2026 | Diário |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 3.286 SH | 2 de Outubro de 2026 | Diário |
| IBB · iShares Trust | 0,01% | 281.381 SH | 11 de Setembro de 2026 | Diário |
BCYC Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 16 analistas
COMPRA
Alvo mediano
$9.50
+181,1%
5 31,2%
Compra forte
7 43,8%
Compra
4 25,0%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
6 analistas · 2026-09-28Alvo médio $9.50 +181,1%
← Abaixo de todos os alvos
Preço atual $3.38
Mín$5.00
Média$9.50
Máx$14.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Jul 30, 2026